Bibliografía del artículo
1. Reder AT, Antel JP. Clinical spectrum of multiple sclerosis. Neurol Clin 1983; 1(3):573-99.
2. Krupp LB, Coyle PK, Doscher C, et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45(11):1956-61.
3. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 1996; 9(6):456-60.
4. Iriarte J, Katsamakis G, De Castro P. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 1999; 5(1):10-6.
5. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14(6):540-5.
6. Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 2004; 61(4):525-8.
7. Frauscher B, Egg R, Brandauer E, et al. Daytime sleepiness is not increased in mild to moderate multiple sclerosis: a pupillographic study. Sleep Med 2005; 6(6):543-7.
8. Danker-Hopfe H, Kraemer S, Dorn H, Schmidt A, Ehlert I, Herrmann WM. Time-of-day variations in different measures of sleepiness (MSLT, pupillography, and SSS) and their interrelations. Psychophysiology 2001; 38(5):828-35.
9. Wilhelm B, Wilhelm H, Ludtke H, Streicher P, Adler M. Pupillographic assessment of sleepiness in sleep-deprived healthy subjects. Sleep 1998; 21(3):258-65.
10. Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 2005; 11(5):592-601.
11. Strober LB, Arnett PA. An examination of four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol 2005; 20(5):631-46.
12. Alarcia R, Ara JR, Martin J, Bertol V, Bestue M. Importance and factors related to chronic fatigue in multiple sclerosis. Neurologia 2005; 20(2):77-84.
13. Alarcia R, Ara JR, Martin J, et al. Sleep disorders in multiple sclerosis. Neurologia 2004; 19(10):704-9.
14. Merkelbach S, Schulz H. What have fatigue and sleepiness in common? J Sleep Res 2006; 15(1):105-6.
15. Gottschalk M, Kumpfel T, Flachenecker P, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 2005; 62(2):277-80.
16. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005; 90(5):3106-14.
17. Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 2006; 58(1):46-57.
18. Kato T, Kanbayashi T, Yamamoto K, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 2003; 42(8):743-5.
19. Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 2005; 64(7):1139-43.